Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders
Timothy A. Couttas, Anna E. Hoffmann, Beverly Jieu, Felix R. Golla, Claire E. Shepherd, F. Markus Leweke, Cathrin Rohleder · 2026
Read Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders by Timothy A. Couttas, Anna E. Hoffmann, Beverly Jieu, Felix R. Golla, Claire E. Shepherd, F. Markus Leweke, Cathrin Rohleder (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13219800.txt.
Description
Timothy A. Couttas and colleagues update the case for blocking one enzyme to raise the brain's cannabis-like signaling in a 2026 review. Anandamide is a lipid messenger that calms synaptic activity, and fatty acid amide hydrolase, or FAAH, is the enzyme that destroys it. Because this endocannabinoid system goes awry in depression, psychosis, and post-traumatic stress, slowing the enzyme is an alternative to cannabis, with side effects and patchy evidence.
The review gathers the clinical trial record for FAAH inhibitors, which raise anandamide along with two lipids. Only two compounds have reached trials. They showed benefit in cannabis use disorder, but no success in post-traumatic stress disorder or osteoarthritis pain, an outcome pattern the authors examine. Safety and the biology of the lipids complicate the picture. Rather than abandoning the strategy, the authors advocate precision medicine: matching drugs to the patients whose endocannabinoid disturbance it can correct.
Catalog record
| CREATOR | Timothy A. Couttas, Anna E. Hoffmann, Beverly Jieu, Felix R. Golla, Claire E. Shepherd, F. Markus Leweke, Cathrin Rohleder |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |